JLL acts for Pfizer as they renew their lease for major UK life sciences facility at Discovery Park, Sandwich, Kent
News release
16 October 2022
Pfizer extends its lease at Sandwich site
Your browser doesn't support speech synthesis.
Listen to article •
Read time: 1 sec
JLL acts for Pfizer as they extend their lease for 10 years at Discovery Park, Sandwich. The space totals some 335,000 sq ft, spread across three main buildings, including traditional laboratories, a pilot plant and manufacturing facilities for clinical trials.
Eamon Burke, Lease Advisory Director at JLL said, “We’re delighted to have acted for Pfizer on these important lease renewals, strengthening our partnership. Sandwich is a hub for innovation, technology and is rich with history, renowned for being the birthplace to several of Pfizer’s most important and most well-known medicines.”
About JLL
JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $19.4 billion, operations in over 80 countries and a global workforce of more than 102,000 as of June 30, 2022. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.